Bank of Montreal Can increased its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 0.5% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,708,937 shares of the medical technology company’s stock after buying an additional 7,886 shares during the period. Bank of Montreal Can’s holdings in Hill-Rom were worth $161,325,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also modified their holdings of the company. Marshall Wace LLP bought a new position in Hill-Rom in the second quarter worth approximately $10,392,000. Millennium Management LLC increased its position in shares of Hill-Rom by 32.3% during the second quarter. Millennium Management LLC now owns 583,635 shares of the medical technology company’s stock worth $50,975,000 after purchasing an additional 142,654 shares in the last quarter. WBI Investments Inc. acquired a new position in shares of Hill-Rom during the second quarter worth $2,150,000. Gateway Investment Advisers LLC acquired a new position in shares of Hill-Rom during the second quarter worth $2,158,000. Finally, BTIM Corp. acquired a new position in shares of Hill-Rom during the second quarter worth $19,352,000. 84.83% of the stock is owned by institutional investors.
A number of brokerages have recently issued reports on HRC. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a research report on Monday, July 2nd. Raymond James upped their price target on Hill-Rom from $97.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, July 30th. Morgan Stanley upped their price target on Hill-Rom from $95.00 to $100.00 and gave the stock an “equal weight” rating in a research report on Thursday. Northcoast Research reaffirmed a “buy” rating and set a $104.00 price target on shares of Hill-Rom in a research report on Tuesday, July 31st. Finally, ValuEngine downgraded Hill-Rom from a “buy” rating to a “hold” rating in a research report on Thursday, October 4th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Hill-Rom presently has an average rating of “Buy” and a consensus price target of $100.00.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, July 27th. The medical technology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. The firm had revenue of $708.60 million for the quarter, compared to analyst estimates of $707.50 million. Hill-Rom had a net margin of 8.19% and a return on equity of 20.54%. The business’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.91 earnings per share. On average, analysts predict that Hill-Rom Holdings, Inc. will post 4.64 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 28th. Stockholders of record on Friday, September 21st were issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend was Thursday, September 20th. Hill-Rom’s dividend payout ratio (DPR) is presently 20.73%.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and communications technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Featured Story: Hedge Funds – How They Work For Investors
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.